Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats
Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. To investigate the effect of RGZ on hepatic steato...
Saved in:
Published in | PloS one Vol. 6; no. 2; p. e17057 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
23.02.2011
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis.
To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg·kg⁻¹·day⁻¹) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes.
RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-α (Ppargc1a/PGC1-α) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-α and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects.
Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis. |
---|---|
AbstractList | BACKGROUND: Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. METHODS: To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg·kg⁻¹·day⁻¹) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. RESULTS: RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-α (Ppargc1a/PGC1-α) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-α and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. CONCLUSION: Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis. Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg·kg⁻¹·day⁻¹) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-α (Ppargc1a/PGC1-α) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-α and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis. Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg·kg.sup.-1 ·day.sup.-1) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-[alpha] (Ppargc1a/PGC1-[alpha]) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-[alpha] and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis. Background Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. Methods To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg·kg−1·day−1) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. Results RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-α (Ppargc1a/PGC1-α) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-α and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. Conclusion Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis. Background Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. Methods To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg·kg.sup.-1 ·day.sup.-1) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. Results RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-[alpha] (Ppargc1a/PGC1-[alpha]) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-[alpha] and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. Conclusion Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis. Background Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. Methods To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg·kg−1·day−1) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. Results RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-α (Ppargc1a/PGC1-α) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-α and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. Conclusion Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis. |
Audience | Academic |
Author | Kim, Sun Woo Oh, Ki Won Chae, Seoung Wan Park, Se Eun Rhee, Eun Jung Kim, Won Jun Yang, Soo Jin Choi, Jung Mook Lee, Won Young Park, Sung Woo Park, Cheol-Young |
AuthorAffiliation | 2 Department of Pathology, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea 3 Department of Endocrinology and Metabolism, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea Mayo Clinic, United States of America 1 Diabetes Research Institute, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea |
AuthorAffiliation_xml | – name: 1 Diabetes Research Institute, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea – name: Mayo Clinic, United States of America – name: 2 Department of Pathology, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea – name: 3 Department of Endocrinology and Metabolism, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Soo Jin surname: Yang fullname: Yang, Soo Jin organization: Diabetes Research Institute, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea – sequence: 2 givenname: Jung Mook surname: Choi fullname: Choi, Jung Mook – sequence: 3 givenname: Seoung Wan surname: Chae fullname: Chae, Seoung Wan – sequence: 4 givenname: Won Jun surname: Kim fullname: Kim, Won Jun – sequence: 5 givenname: Se Eun surname: Park fullname: Park, Se Eun – sequence: 6 givenname: Eun Jung surname: Rhee fullname: Rhee, Eun Jung – sequence: 7 givenname: Won Young surname: Lee fullname: Lee, Won Young – sequence: 8 givenname: Ki Won surname: Oh fullname: Oh, Ki Won – sequence: 9 givenname: Sung Woo surname: Park fullname: Park, Sung Woo – sequence: 10 givenname: Sun Woo surname: Kim fullname: Kim, Sun Woo – sequence: 11 givenname: Cheol-Young surname: Park fullname: Park, Cheol-Young |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21373642$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk9uK2zAQhk3Z0j20b1BaQaHQi6SSZcnxzUJYeggsLPR0K8byyFGwLVdylmyfow9cZeNdYmih-EJm9P3_jEaa8-Skcx0myUtG54zn7P3GbX0HzbyP4TmlLKcif5KcsYKnM5lSfnL0f5qch7ChVPCFlM-S0zQ6cJmlZ8nvpR7sLQzWdcQZ0qN3Oxtci6T3rrEGPQzOz-BAYUU8auxjiNTQtkDKO-JdsHVjB_gVKyG20x4hYCDB-kES3PUeQ9j7Q1cRaLGxLppGYI19TKxJGDAmCTZEMYlb4Xny1EAT8MW4XiTfP374dvV5dn3zaXW1vJ5pWbBhVrEFAk2FKFglOc9TMKwwhciyEijPsRRMVHIhsoqLMjdMVrQQPOMmYxoAJL9IXh98-8YFNTY0KJYWMuOFYGkkVgeicrBRvbct-DvlwKr7gPO1Ah_P0KCiEhc6l0VlgGcSeWk05YtS8qLCtDD7bJdjtm3ZYqWxGzw0E9PpTmfXqna3itMsY0JEgzejgXc_txiGf5Q8UjXEqmxnXDTTrQ1aLbNYXyzq3mv-Fyp-FbZWx4s0NsYngncTQWQG3A01bENQq69f_p-9-TFl3x6xa4RmWAfXbPcvMkzB7ADq-OCCR_PYOUbVfiIeuqH2E6HGiYiyV8ddfxQ9jAD_A2LPDBA |
CitedBy_id | crossref_primary_10_3389_fphys_2018_00135 crossref_primary_10_1096_fj_201900767R crossref_primary_10_14336_AD_2022_0413 crossref_primary_10_1002_med_21753 crossref_primary_10_1016_j_freeradbiomed_2012_10_525 crossref_primary_10_1155_2020_3817573 crossref_primary_10_1111_jnc_12190 crossref_primary_10_1016_j_tibs_2013_12_002 crossref_primary_10_3390_biomedicines11020354 crossref_primary_10_1186_s12974_019_1432_5 crossref_primary_10_1074_jbc_M114_633198 crossref_primary_10_1093_carcin_bgv167 crossref_primary_10_1177_0960327115608246 crossref_primary_10_1089_ars_2017_7313 crossref_primary_10_1371_journal_pone_0051357 crossref_primary_10_1186_1479_7364_5_5_485 crossref_primary_10_1016_j_arr_2016_10_008 crossref_primary_10_3390_ijms20051153 crossref_primary_10_1016_j_ejphar_2012_10_006 crossref_primary_10_7570_kjo_2011_20_4_161 crossref_primary_10_1177_1470320313499199 crossref_primary_10_1002_jcp_27213 crossref_primary_10_1007_s00018_021_04061_9 crossref_primary_10_1152_ajpgi_00165_2016 crossref_primary_10_1016_j_jnutbio_2014_10_010 crossref_primary_10_1194_jlr_M039339 crossref_primary_10_1096_fj_201600410RR crossref_primary_10_1371_journal_pone_0120380 crossref_primary_10_1155_2013_342648 crossref_primary_10_1371_journal_pone_0179681 crossref_primary_10_1016_j_jnutbio_2013_09_004 crossref_primary_10_3748_wjg_v21_i25_7754 crossref_primary_10_3389_fendo_2018_00748 crossref_primary_10_1016_j_bbrc_2014_08_122 crossref_primary_10_1371_journal_pone_0105456 crossref_primary_10_1016_j_lfs_2021_119803 crossref_primary_10_1038_s41420_022_00889_7 crossref_primary_10_1111_bph_14434 crossref_primary_10_3390_ijms20081885 crossref_primary_10_1016_S1665_2681_19_30787_2 crossref_primary_10_1155_2012_912351 crossref_primary_10_1172_jci_insight_120794 crossref_primary_10_1111_bcpt_13621 crossref_primary_10_1111_j_2040_1124_2012_00204_x crossref_primary_10_18632_oncotarget_21852 crossref_primary_10_1021_pr401230s crossref_primary_10_1038_s41598_017_02332_9 crossref_primary_10_1096_fj_202301012R crossref_primary_10_1016_j_bbalip_2022_159246 crossref_primary_10_1089_gtmb_2015_0188 crossref_primary_10_1093_ajh_hpv065 crossref_primary_10_1038_s41598_018_22388_5 crossref_primary_10_1016_j_bbrc_2016_06_102 crossref_primary_10_3349_ymj_2013_54_5_1127 crossref_primary_10_1111_jdi_12107 crossref_primary_10_1007_s12012_024_09858_1 crossref_primary_10_3390_ijms23031062 crossref_primary_10_1016_j_biopha_2017_01_035 crossref_primary_10_1016_j_metabol_2014_04_011 crossref_primary_10_1016_j_phrs_2020_105214 crossref_primary_10_1530_JME_12_0119 crossref_primary_10_3390_ijms141122933 |
Cites_doi | 10.1002/hep.20701 10.1074/jbc.M110.168039 10.1038/nature07813 10.1002/hep.20012 10.1016/j.bbrc.2003.12.120 10.1172/JCI200422422 10.1172/JCI10843 10.1016/j.cmet.2009.02.006 10.1111/j.1742-7843.2010.00553.x 10.1053/j.gastro.2008.03.078 10.1152/ajpendo.00453.2005 10.1016/j.metabol.2009.07.004 10.2174/1566524053766031 10.1016/j.cell.2005.11.044 10.1111/j.1474-9726.2009.00544.x 10.1161/01.ATV.0000200136.56716.30 10.1053/gast.2002.36572 10.1038/nature05486 10.1038/nm788 10.2337/diabetes.46.9.1393 10.1152/ajpendo.90997.2008 10.1073/pnas.1934713100 10.1074/jbc.M805711200 10.2337/diabetes.53.4.1052 10.1073/pnas.0802917105 10.1053/jhep.2003.50193 10.1073/pnas.0400593101 10.1016/j.cmet.2010.02.006 10.1074/jbc.M802187200 10.1016/j.bbrc.2009.01.163 10.2337/diabetes.53.2007.S43 10.1146/annurev.pathol.4.110807.092250 10.3748/wjg.14.185 10.1210/jc.2006-1268 10.1038/nature03354 10.1101/gad.1467506 10.1038/nm1557 10.1016/j.cmet.2010.06.009 10.1152/ajpgi.00456.2009 10.2337/diabetes.52.6.1364 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2011 Public Library of Science 2011 Yang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Yang et al. 2011 |
Copyright_xml | – notice: COPYRIGHT 2011 Public Library of Science – notice: 2011 Yang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Yang et al. 2011 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PIMPY PQEST PQQKQ PQUKI PRINS PTHSS PYCSY RC3 5PM DOA |
DOI | 10.1371/journal.pone.0017057 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints In Context Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing and Allied Health Journals Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Biological Science Collection ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic Technology Collection Technology Research Database Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE Agricultural Science Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Medicine Biology |
DocumentTitleAlternate | Rosiglitazone, Sirt6 and Hepatic Steatosis |
EISSN | 1932-6203 |
Editor | Lanza, Ian |
Editor_xml | – sequence: 1 givenname: Ian surname: Lanza fullname: Lanza, Ian |
ExternalDocumentID | 1296439512 oai_doaj_org_article_06e8c769dfa346e3bfc038b639de29f6 2898836241 A476903855 10_1371_journal_pone_0017057 21373642 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF D1I D1J D1K DIK DU5 E3Z EAP EAS EBD ECM EIF EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ NPM O5R O5S OK1 P2P P62 PATMY PDBOC PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RIG RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM AAYXX CITATION 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PQEST PQUKI PRINS RC3 5PM - 02 AAPBV ABPTK ADACO BBAFP KM |
ID | FETCH-LOGICAL-c691t-d18ea025591d63372af19f9544ba037eb515d6854d35b7f16d095343f41caaa63 |
IEDL.DBID | RPM |
ISSN | 1932-6203 |
IngestDate | Fri Nov 26 17:22:20 EST 2021 Fri Jul 05 11:45:58 EDT 2024 Tue Sep 17 21:26:40 EDT 2024 Fri Sep 13 07:31:36 EDT 2024 Thu Feb 22 23:27:43 EST 2024 Fri Feb 02 04:10:15 EST 2024 Thu Aug 01 19:41:03 EDT 2024 Thu Aug 01 19:32:12 EDT 2024 Tue Aug 20 22:11:59 EDT 2024 Fri Aug 23 00:43:06 EDT 2024 Tue Aug 27 13:51:58 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c691t-d18ea025591d63372af19f9544ba037eb515d6854d35b7f16d095343f41caaa63 |
Notes | Conceived and designed the experiments: SJY CYP. Performed the experiments: SJY JMC. Analyzed the data: SJY JMC SWC WJK SEP EJR WYL KWO SWP SWK CYP. Wrote the paper: SJY. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044155/ |
PMID | 21373642 |
PQID | 1296439512 |
PQPubID | 1436336 |
PageCount | e17057 |
ParticipantIDs | plos_journals_1296439512 doaj_primary_oai_doaj_org_article_06e8c769dfa346e3bfc038b639de29f6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3044155 proquest_journals_1296439512 gale_infotracmisc_A476903855 gale_infotracacademiconefile_A476903855 gale_incontextgauss_ISR_A476903855 gale_incontextgauss_IOV_A476903855 gale_healthsolutions_A476903855 crossref_primary_10_1371_journal_pone_0017057 pubmed_primary_21373642 |
PublicationCentury | 2000 |
PublicationDate | 2011-02-23 |
PublicationDateYYYYMMDD | 2011-02-23 |
PublicationDate_xml | – month: 02 year: 2011 text: 2011-02-23 day: 23 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2011 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | JD Browning (ref1) 2004; 114 X Hou (ref23) 2008; 283 F Lan (ref24) 2008; 283 R Mostoslavsky (ref25) 2006; 124 JG Kang (ref10) 2010; 59 JM Olefsky (ref6) 2000; 106 Q Liu (ref30) 2010 L Guarente (ref20) 2006; 444 M Bajaj (ref11) 2003; 52 HS Kim (ref36) 2010; 12 FF Samaha (ref17) 2006; 26 PT Pfluger (ref22) 2008; 105 AK Saha (ref14) 2004; 314 BA Neuschwander-Tetri (ref3) 2003; 37 C Canto (ref34) 2009; 458 HL Cheng (ref41) 2003; 100 AJ Sanyal (ref5) 2002; 123 B Brunmair (ref16) 2004; 53 JT Rodgers (ref32) 2005; 434 C Canto (ref35); 11 C Xiao (ref37) 2010; 285 P Ferre (ref7) 2004; 53 GL Wang (ref38) 2009; 380 RS Rector (ref4) 2008; 14 Z Ackerman (ref13) 2010; 107 Z Shen (ref40) 2010; 298 A Purushotham (ref21) 2009; 9 V Ratziu (ref28) 2008; 135 Y Kanfi (ref26) 2010; 9 T Yamauchi (ref31) 2007; 13 MC Haigis (ref19) 2006; 20 H Daitoku (ref33) 2004; 101 Y Yamazaki (ref39) 2009; 297 S Hallakou (ref8) 1997; 46 MC Haigis (ref18) 2010; 5 K Promrat (ref12) 2004; 39 NK LeBrasseur (ref15) 2006; 291 H Yki-Jarvinen (ref2) 2005; 5 T Yamauchi (ref29) 2002; 8 AM Sharma (ref9) 2007; 92 DE Kleiner (ref27) 2005; 41 |
References_xml | – volume: 41 start-page: 1313 year: 2005 ident: ref27 article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. publication-title: Hepatology doi: 10.1002/hep.20701 contributor: fullname: DE Kleiner – volume: 285 start-page: 36776 year: 2010 ident: ref37 article-title: SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. publication-title: J Biol Chem doi: 10.1074/jbc.M110.168039 contributor: fullname: C Xiao – volume: 458 start-page: 1056 year: 2009 ident: ref34 article-title: AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. publication-title: Nature doi: 10.1038/nature07813 contributor: fullname: C Canto – volume: 39 start-page: 188 year: 2004 ident: ref12 article-title: A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. publication-title: Hepatology doi: 10.1002/hep.20012 contributor: fullname: K Promrat – volume: 314 start-page: 580 year: 2004 ident: ref14 article-title: Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2003.12.120 contributor: fullname: AK Saha – volume: 114 start-page: 147 year: 2004 ident: ref1 article-title: Molecular mediators of hepatic steatosis and liver injury. publication-title: J Clin Invest doi: 10.1172/JCI200422422 contributor: fullname: JD Browning – volume: 106 start-page: 467 year: 2000 ident: ref6 article-title: Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. publication-title: J Clin Invest doi: 10.1172/JCI10843 contributor: fullname: JM Olefsky – volume: 9 start-page: 327 year: 2009 ident: ref21 article-title: Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. publication-title: Cell Metab doi: 10.1016/j.cmet.2009.02.006 contributor: fullname: A Purushotham – volume: 107 start-page: 663 year: 2010 ident: ref13 article-title: Hepatic Effects of Rosiglitazone in Rats with the Metabolic Syndrome. publication-title: Basic Clin Pharmacol Toxicol doi: 10.1111/j.1742-7843.2010.00553.x contributor: fullname: Z Ackerman – volume: 135 start-page: 100 year: 2008 ident: ref28 article-title: Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.03.078 contributor: fullname: V Ratziu – volume: 291 start-page: E175 year: 2006 ident: ref15 article-title: Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00453.2005 contributor: fullname: NK LeBrasseur – volume: 59 start-page: 46 year: 2010 ident: ref10 article-title: Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots. publication-title: Metabolism doi: 10.1016/j.metabol.2009.07.004 contributor: fullname: JG Kang – volume: 5 start-page: 287 year: 2005 ident: ref2 article-title: The fatty liver and insulin resistance. publication-title: Curr Mol Med doi: 10.2174/1566524053766031 contributor: fullname: H Yki-Jarvinen – volume: 124 start-page: 315 year: 2006 ident: ref25 article-title: Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. publication-title: Cell doi: 10.1016/j.cell.2005.11.044 contributor: fullname: R Mostoslavsky – year: 2010 ident: ref30 article-title: Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio. publication-title: FASEB J contributor: fullname: Q Liu – volume: 9 start-page: 162 year: 2010 ident: ref26 article-title: SIRT6 protects against pathological damage caused by diet-induced obesity. publication-title: Aging Cell doi: 10.1111/j.1474-9726.2009.00544.x contributor: fullname: Y Kanfi – volume: 26 start-page: 624 year: 2006 ident: ref17 article-title: Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000200136.56716.30 contributor: fullname: FF Samaha – volume: 123 start-page: 1705 year: 2002 ident: ref5 article-title: AGA technical review on nonalcoholic fatty liver disease. publication-title: Gastroenterology doi: 10.1053/gast.2002.36572 contributor: fullname: AJ Sanyal – volume: 444 start-page: 868 year: 2006 ident: ref20 article-title: Sirtuins as potential targets for metabolic syndrome. publication-title: Nature doi: 10.1038/nature05486 contributor: fullname: L Guarente – volume: 8 start-page: 1288 year: 2002 ident: ref29 article-title: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. publication-title: Nat Med doi: 10.1038/nm788 contributor: fullname: T Yamauchi – volume: 46 start-page: 1393 year: 1997 ident: ref8 article-title: Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. publication-title: Diabetes doi: 10.2337/diabetes.46.9.1393 contributor: fullname: S Hallakou – volume: 297 start-page: E1179 year: 2009 ident: ref39 article-title: Treatment with SRT1720, a SIRT1 Activator, Ameliorates Fatty Liver with Reduced Expression of Lipogenic Enzymes in MSG Mice. publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.90997.2008 contributor: fullname: Y Yamazaki – volume: 100 start-page: 10794 year: 2003 ident: ref41 article-title: Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1934713100 contributor: fullname: HL Cheng – volume: 283 start-page: 27628 year: 2008 ident: ref24 article-title: SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. publication-title: J Biol Chem doi: 10.1074/jbc.M805711200 contributor: fullname: F Lan – volume: 53 start-page: 1052 year: 2004 ident: ref16 article-title: Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? publication-title: Diabetes doi: 10.2337/diabetes.53.4.1052 contributor: fullname: B Brunmair – volume: 105 start-page: 9793 year: 2008 ident: ref22 article-title: Sirt1 protects against high-fat diet-induced metabolic damage. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0802917105 contributor: fullname: PT Pfluger – volume: 37 start-page: 1202 year: 2003 ident: ref3 article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. publication-title: Hepatology doi: 10.1053/jhep.2003.50193 contributor: fullname: BA Neuschwander-Tetri – volume: 101 start-page: 10042 year: 2004 ident: ref33 article-title: Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0400593101 contributor: fullname: H Daitoku – volume: 11 start-page: 213 ident: ref35 article-title: Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. publication-title: Cell Metab doi: 10.1016/j.cmet.2010.02.006 contributor: fullname: C Canto – volume: 283 start-page: 20015 year: 2008 ident: ref23 article-title: SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. publication-title: J Biol Chem doi: 10.1074/jbc.M802187200 contributor: fullname: X Hou – volume: 380 start-page: 644 year: 2009 ident: ref38 article-title: Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2009.01.163 contributor: fullname: GL Wang – volume: 53 start-page: S43 year: 2004 ident: ref7 article-title: The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. publication-title: Diabetes doi: 10.2337/diabetes.53.2007.S43 contributor: fullname: P Ferre – volume: 5 start-page: 253 year: 2010 ident: ref18 article-title: Mammalian sirtuins: biological insights and disease relevance. publication-title: Annu Rev Pathol doi: 10.1146/annurev.pathol.4.110807.092250 contributor: fullname: MC Haigis – volume: 14 start-page: 185 year: 2008 ident: ref4 article-title: Non-alcoholic fatty liver disease and the metabolic syndrome: an update. publication-title: World J Gastroenterol doi: 10.3748/wjg.14.185 contributor: fullname: RS Rector – volume: 92 start-page: 386 year: 2007 ident: ref9 article-title: Review: Peroxisome proliferator-activated receptor gamma and adipose tissue–understanding obesity-related changes in regulation of lipid and glucose metabolism. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1268 contributor: fullname: AM Sharma – volume: 434 start-page: 113 year: 2005 ident: ref32 article-title: Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. publication-title: Nature doi: 10.1038/nature03354 contributor: fullname: JT Rodgers – volume: 20 start-page: 2913 year: 2006 ident: ref19 article-title: Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction. publication-title: Genes Dev doi: 10.1101/gad.1467506 contributor: fullname: MC Haigis – volume: 13 start-page: 332 year: 2007 ident: ref31 article-title: Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. publication-title: Nat Med doi: 10.1038/nm1557 contributor: fullname: T Yamauchi – volume: 12 start-page: 224 year: 2010 ident: ref36 article-title: Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. publication-title: Cell Metab doi: 10.1016/j.cmet.2010.06.009 contributor: fullname: HS Kim – volume: 298 start-page: G364 year: 2010 ident: ref40 article-title: Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00456.2009 contributor: fullname: Z Shen – volume: 52 start-page: 1364 year: 2003 ident: ref11 article-title: Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. publication-title: Diabetes doi: 10.2337/diabetes.52.6.1364 contributor: fullname: M Bajaj |
SSID | ssj0053866 |
Score | 2.3390203 |
Snippet | Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the... Background Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to... BACKGROUND: Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to... Background Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to... |
SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e17057 |
SubjectTerms | Accumulation Activation AMP AMP-activated protein kinase Animals Biology Cells, Cultured Drug Evaluation, Preclinical Fatty acids Fatty liver Fatty Liver - drug therapy Fatty Liver - genetics Fatty Liver - metabolism Fatty Liver - pathology Forkhead protein FOXO1 protein Gene expression Gene Expression Regulation, Enzymologic - drug effects Glucose Hepatocytes Hypolipidemic Agents - pharmacology Insulin resistance Kinases Lipid metabolism Lipid Metabolism - drug effects Lipid Metabolism - genetics Liver Liver - drug effects Liver - metabolism LKB1 protein Male Medicine Metabolism Mice mRNA Phosphorylation Physiological aspects PPAR gamma - agonists PPAR gamma - metabolism Rats Rats, Inbred OLETF Rats, Long-Evans RNA Rodents Rosiglitazone Sirtuins - genetics Sirtuins - metabolism Sirtuins - physiology Steatosis Stomach Thiazolidinediones Thiazolidinediones - pharmacology Thiazolidinediones - therapeutic use Triglycerides |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyqtLC1gICTikjWPHSY4LoipIgAQU9Rb5uY3UTVbNVir8Dn4wM7GzalAlOHCNx7vOPOyZeOYbQl6kSrHUmDIpXeUT4Rw2cnc2gUjMVHmGRzpWI3_8JI9PxIfT_PRaqy_MCQvwwIFxh6l0pSlkZb3iQjquvUl5qeFgtS6rfADbZvkYTIU9GKxYylgoxwt2GOVysO5adxAgZIrJQTTg9W935dn6vOtvcjn_zJy8dhQd3SV3og9JF2HtO-SWa--RnWilPX0VoaRf3ye_FmZsX0Y7TxEU_Krpu5Wja-zW491wyZ6oQOUshf3PreERXarVSlH9g8LimyUief-Et6JNi15mD__SNxcbSd1VTKRtqWotVSt3jjX_4L_SM4fJ2oaiGm3gR3qYTGGof0BOjt59e3ucxD4MiZEV2ySWlU4NsQezkvMiU55VvsqF0CrlhdPgE1lZ5sLyXBeeSYsgdoJ7wYxSSvKHZNbCGncJdaXg3ICXojItrNQq84rZUrO8tLrI2Zwko1DqdYDbqIc7twLClMDdGoVYRyHOyRuU3JYWwbKHB6BCdVSh-m8qNCfPUO51qDzdmny9EDAJb07zOXk-UCBgRosZOUt12ff1-8_f_4Ho65cJ0ctI5DvQIKNiFQS8EwJxTSj3J5Rg9mYyvItaOnKlrxleoHNwmDOYOWruzcOPghJvuZYBfzkEonNSTNR7wtbpSNucDVjkPMWAPH_8P-SwR26HL_ZZkvF9MttcXLon4PJt9NPBun8D7ElY0Q priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnytMMBCSMBD1jh2nOQJdaijIDGqjqG9Rf7sKq1JaTJp8HfwB-NLnELQhHiNL1--D599d79D6GUoBAmVSoPUZDZgxkAjd6MDtxNTWRzBkg7VyJ9O-PSMfTyPz3fQtKuFgbTKziY2hlqXCs7IRwTig9T5A9FISDgFUPXo7fpbAP2jIM7qm2ncQrsRYRCw3T2anMzmnVV2es25L52jCRl5Th2uy8IctqAySW9pahD8t3Z6sL4sq5uc0L9zKf9YnI7vojveq8TjVgz20I4p7qE9r7cVfu3Bpd_cRz_HqmtohkuLZ2ZTXi-rcmXwDPr3WNOE3QNPZTR2fqVZu0v4vVitBJbf8byslgvA9v7h_go7AwN57e4tp8tNzfHk2qfWFlgUGo9X5hJQAJxHi6cG0rcVhhzi2j2kwssCz0VdPUBnx5Mv76aB78wQKJ6ROtAkNaLZjRDNKU0iYUlms5gxKUKaGOm8JM3TmGkay8QSrgHWjlHLiBJCcPoQDQr3jfsIm5RRqpzfIiLJNJcisoLoVJI41TKJyRAFHVPydQvAkTdRuMRtXNrZzYGJuWfiEB0B57a0AJ_dXCg3i9xrYx5yk6qEZ9oKyrih0qqQptJ5a9pEmeVD9Bz4nre1qFsjkI-ZuwliqfEQvWgoAEKjgBydhbiqqvzD56__QXQ67xG98kS2BLEWvi7C_RNAc_UoD3qUzhCo3vA-SGk3K1X-W2XcnZ3k3jz8qBXi7axFbn6p25oOUdIT79609keK5UWDTk5D2KLHj__9yifodns6HwURPUCDenNlnjr3rpbPvOb-Ak_ZUy8 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELaWcuGCWF4bWMBCSMAhVRw7TnJAqCBWC9KCBBTtLXL86FZqk9J0pS6_gx_MTOJUBHUlrvFMHvOwZzL2N4S8iJRikdZZmNnchcJabORuTQiZmM6TGJd0PI189lmeTsWn8-T8gPQ9W70Am72pHfaTmq4X4-3Pq7fg8G_arg0p65nGq7qy4w4gJr1BbsaCC7T5M7GrK4B3S-kP0F3H2cID85RLEQ_WqhbSfzdxj1aLutkXlf67ufKv1erkDrntw0w66ezikBzY6i459I7c0Fcebfr1PfJ7ovsOZ7R2FHHDt_OmXlq6woY-zrZ1-FB1VNZQmCLtCi7RmVouFS2vKLz8fIZg37_gA-m8wkC0gac08_VGUrv1e20rqipD1dIuEBYAQlx6YXE_t6ZoaRu4SQPMFIaa-2R68uH7-9PQt2oItczZJjQss6pNT5iRnKexcix3eSJEqSKe2hLCJiOzRBielKlj0iDOneBOMK2UkvwBGVXwjkeE2kxwriGQUXEpjCxV7BQzWcmSzJRpwgIS9kopVh0iR9GW5VLIZDrpFqjPwuszIO9QcztaxNNuL9TrWeHds4ikzXQqc-MUGI3lpdMRz0oI34yNcycD8gz1XnSHU3ezQjERwITF1SQgz1sKxNSocNPOTF02TfHxy4__IPr2dUD00hO5GixIK39QAr4JsboGlMcDSpgZ9GD4CK20l0pTMKyxc4ipY-DsLXf_8MPOiHdS610iIOnAvAdiHY5U84sWrpxHmLMnj66952Nyq_tTH4cxPyajzfrSPoFQb1M-bb33D0mbVVE priority: 102 providerName: Scholars Portal |
Title | Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21373642 https://www.proquest.com/docview/1296439512/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC3044155 https://doaj.org/article/06e8c769dfa346e3bfc038b639de29f6 http://dx.doi.org/10.1371/journal.pone.0017057 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELe2IhAviBXYCqNYCAl4SFvHjpM8dlW7gtRRdQztLXJsp1RqkqrppI0HPgUfmHPiVATtAfHih_icP_bd-S53_h1C7wZCkIGUgRPoMHGY1qaQu1YOeGIy9FyzpZvTyLMLPr1in6-96wPk1WdhyqR9Ga962TrtZavvZW7lJpX9Ok-sP5-NwAU3-2D_EB36lNYueqV-QYA5t2fkqE_6dkl6mzzTvQo9xi8RgKlPOXMb21GJ2r_Xza3NOi_uMzz_zp_8Y0OaPEVPrCWJh9UbH6EDnbXRw6q25F0bPZrZqHkbHVkBLvAHizL98Rn6NZR1ZTOcJ3iut_ntqshTjeemkE-iy_i7Y6m0wmBg6g1cwuciTQWO7_AiL1ZLA_L9A74ag6YxCe7wlMvVdsfx-Nbm2GZYZAoPU702cABg2uKpNnncEptk4h3cpMCrDC_ErniOribjr6OpY0s0OJKHZOcoEmhRuiVEcUp9VyQkTEKPsVgMqK9jMJcUDzymqBf7CeHK4NsxmjAihRCcvkCtDN7xBGEdMEolGDDCjZnisXATQVQQEy9Qse-RDnLqlYo2FRJHVIbjfPBgqimPzCJHdpE76Mws557W4GiXF_LtMrLcFA24DqTPQ5UIyrimcSIHNIjBbFPaDRPeQW8MM0TVodS9NoiGDAaZoKrXQW9LCoOlkZlknaW4KYro05dv_0B0uWgQvbdESQ5sJYU9IAHfZDC6GpSnDUrQCLLRfWJYt56VIiImtk7BlnZhZM3O93cfV5y9n7VaTjrIb_B8Y1qbPSC1JUy5ldKX_z3yFXpc_cF3HZeeotZue6Nfgwm4i7sg-Nc-tMGImHZy3kUPzsYX80W3_KkC7YwFpv057pbq4TfUb2RM |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,12083,12250,12792,21416,24346,27957,27958,31754,33301,33408,33779,43345,43614,43635,43840,53827,53829,74102,74371,74392,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegPMALYnytMJiFkICHbHHsOMkTKmijg21M3Yb6Fjn-KJXWpDSdNPg7-IO5S9xC0IR4jS9fdz77znf3O0JehkqxUOs0SG3mAmEtNnK3JgBPTGdxhFs6ViMfHcvhufg4jsf-wK32aZWrNbFZqE2l8Yx8l2F8kIM9EL2dfwuwaxRGV30LjZvkluBcYEpfMl47XKDLUvpyOZ6wXS-dnXlV2p0WSCbpbEcNav96be7NL6r6OsPz7_zJPzak_Xvkrrck6aAV_Qa5Ycv7ZMPrak1fe0DpNw_Iz4FeNTGjlaMndlFdTetqZukJ9uxxtgm1B57KGgq2pJ3DJfpBzWaKFt_pqKqnE8Tz_gF_RWFRwVx2eMvpdLGUdO_Kp9OWVJWGDmb2Aiv_wYqlQ4sp25pi3vASHlLTaUlHalk_JOf7e2fvh4HvxhBombFlYFhqVeOBMCM5TyLlWOayWIhChTyxBVhGRqaxMDwuEsekQSg7wZ1gWikl-SPSK-EbNwm1KUhLg62iokIYWajIKWbSgsWpKZKY9UmwEko-b0E38ibyloCz0nI3RyHmXoh98g4lt6ZFyOzmQrWY5F4D81DaVCcyM05xIS0vnA55WoCFZmyUOdkn2yj3vK0_XSt-PhBwE8ZP4z550VAgbEaJeTkTdVnX-cHnL_9BdDrqEL3yRK6CGaSVr4WAf0I4rg7lVocSlF93hjdxlq64Uue_1QTuXM3c64cft5N4zbUI-MvBHe2TpDO9O2ztjpTTrw0iOQ_RLY-f_PuV2-T28OzoMD88OP70lNxpT-ejIOJbpLdcXNpnYN4ti-eNDv8CFEpQ_A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF5BkBAXRHk1UOgKIQEHN16vvbZPKJSGlEeJUlr1Zq33ESI1dohdqfA7-MHM2JuAUYW4esdxPK-d8cx-Q8hzX0rmK5V4iUmtFxqDg9yN9iATU2kU4JaOp5E_HYnxSfj-LDpz_U-Va6tc-8TGUetS4TfyAcP6IId4IBhY1xYxeTt6vfzm4QQprLS6cRrXyQ3YFWM00mR_0-4Bdi2EOzoHiwMnqb1lWZi9FlQm7mxNDYL_xk_3ludldVUQ-ncv5R-b0-gOue2iSjps1WCLXDPFXbLl7LaiLx249Kt75OdQrQea0dLSiVmVl_OqXBg6wfk91jRld89RGU0hrjRLuETfycVC0vw7nZbVfIbY3j_grSg4GOxrh6ccz1e1oAeXrrW2oLLQdLgw54gCABEtHRts31YUe4hr-JGKzgs6lXV1n5yMDr7sjz03mcFTImW1p1liZJONMC04jwNpWWrTKAxz6fPY5BAlaZFEoeZRHlsmNMLahdyGTEkpBX9AegX8x21CTRJyriBukUEeapHLwEqmk5xFic7jiPWJtxZKtmwBOLKmChdD4tJyN0MhZk6IffIGJbehRfjs5kK5mmXOGjNfmETFItVW8lAYnlvl8ySHaE2bILWiT3ZR7ll7FnXjBLJhCDdhLTXqk2cNBUJoFKiMM3lRVdnh59P_IDqedoheOCJbggYp6c5FwDshNFeHcqdDCY5AdZa3UUvXXKmy3yYDd6419-rlh60Sb7gWAH85pKZ9EnfUu8PW7kox_9qgk3MfU_To0b8fuUtugvlmHw-PPjwmt9oP9YEX8B3Sq1cX5glEenX-tDHhX4WSVPw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+peroxisome+proliferator-activated+receptor+gamma+by+rosiglitazone+increases+sirt6+expression+and+ameliorates+hepatic+steatosis+in+rats&rft.jtitle=PloS+one&rft.au=Yang%2C+Soo+Jin&rft.au=Choi%2C+Jung+Mook&rft.au=Chae%2C+Seoung+Wan&rft.au=Kim%2C+Won+Jun&rft.date=2011-02-23&rft.eissn=1932-6203&rft.volume=6&rft.issue=2&rft.spage=e17057&rft_id=info:doi/10.1371%2Fjournal.pone.0017057&rft_id=info%3Apmid%2F21373642&rft.externalDocID=21373642 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |